© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
July 30, 2022
Dr. Kushner discusses obesity as a risk factor for CVD and how preventive cardiologists can better target weight management to support patient health.
July 29, 2022
Dr Peter Kaiser outlines approval process of biosimilars and highlights key differences from approval process of reference products.
An ophthalmology expert provides an overview of biosimilars and their potential in ophthalmology practices.
July 28, 2022
Experts in dermatology comment on the heterogeneity of atopic dermatitis and how this affects clinical practice decisions, patient quality of life, and disease burden.
Raj Chovatiya, MD, PhD; Brittany G. Craiglow, MD; and Peter A. Lio, MD, provide insight into pediatric atopic dermatitis, focusing their discussion on the pathophysiology, prevalence, and disease symptomology.
July 26, 2022
Dr Feuerstadt discusses data with 4 emerging microbiota-based live biotherapeutics for treatment of rCDI: RBX2660, SER-109, CP101, and VE303.
A gastroenterologist summarizes foundational trials that led to the use of fecal microbial transplant for treatment of rCDI.
Dr Paul Feuerstadt provides an overview of Clostridioides difficile infection and why it is challenging to manage recurrent C diff infections (rCDI).
July 25, 2022
Dr. Sanyal talks about the importance in having ongoing real-world data for NAFLD and NASH.
Jennifer Green, MD, discusses the benefit of relatively new innovations including continuous glucose monitoring and smart insulin pens.
FDA Approves Baloxavir Marboxil to Treat, Prevent Flu in Younger At-Risk Children
COVID-19 Vaccination Rates Lower in Adults with Vision, Hearing Disabilities
Kidney-Urinary Tract Involvement with Intermediate Junctional Epidermolysis Bullosa